Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hogy Medical Co's enterprise value is $871.7 Mil.
Hogy Medical Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $44.4 Mil. Therefore, Hogy Medical Co's EV-to-EBITDA for today is 19.62.
The historical rank and industry rank for Hogy Medical Co's EV-to-EBITDA or its related term are showing as below:
HGYMF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.98 Med: 7.68 Max: 21.03
Current: 20.74
During the past 13 years, the highest EV-to-EBITDA of Hogy Medical Co was 21.03. The lowest was 4.98. And the median was 7.68.
HGYMF's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 14.95
vs HGYMF: 20.74
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Hogy Medical Co (OTCPK:HGYMF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hogy Medical Co's PE Ratio (TTM) for today is calculated as:
Hogy Medical Co's share price for today is $34.99.
Hogy Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.093.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Hogy Medical Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Hogy Medical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hogy Medical Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hogy Medical Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Hogy Medical Co's EV-to-EBITDA falls into.
Hogy Medical Co's current Enterprise Value is $871.7 Mil.
Hogy Medical Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $44.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hogy Medical Co (HGYMF) has a EV-to-EBITDA of 19.62 as of Aug. 18, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hogy Medical Co. This is 155% above median its historical median of 7.68. Over the past decade, Hogy Medical Co's EV-to-EBITDA has ranged from 4.98 to 21.03.
Is Hogy Medical Co's EV-to-EBITDA too high?
Hogy Medical Co's current EV-to-EBITDA of 19.62 is 155% above median its 10-year median of 7.68. Over the past 10 years, this metric has ranged from a low of 4.98 to a high of 21.03. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.95. Hogy Medical Co's value of 19.62 is 31.2% above this industry median. Overall, Hogy Medical Co has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hogy Medical Co's EV-to-EBITDA compare to ISRG and BDX?
Hogy Medical Co's EV-to-EBITDA of 19.62 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-EBITDA is 14.95. Hogy Medical Co's value of 19.62 is 31.2% above this benchmark. Historically, Hogy Medical Co's own EV-to-EBITDA has ranged from 4.98 to 21.03 over the past decade. While the company's 10-year median is 7.68 vs. the industry median of 14.95, Hogy Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.95, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hogy Medical Co's current EV-to-EBITDA of 19.62 is 31.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hogy Medical Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hogy Medical Co's current EV-to-EBITDA is 19.62, which is 155% above median its own 10-year median of 7.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hogy Medical Co stock overvalued right now?
Hogy Medical Co (HGYMF) has a current EV-to-EBITDA of 19.62. The stock's GF Value™ is $23.23, compared to a current price of $34.99 — trading 50.6% above its estimated fair value. The current EV-to-EBITDA is 19.62, which is 155% above median its 10-year median of 7.68 and 31.2% above the Medical Devices & Instruments industry median of 14.95. Hogy Medical Co's overall GF Score™ is 57/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Hogy Medical Co (HGYMF), the current EV-to-EBITDA is 19.62 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hogy Medical Co (HGYMF) Overvalued in 2026?
Based on GuruFocus' analysis, Hogy Medical Co stock appears to be overvalued.
The current stock price of $34.99 is trading 50.6% above its estimated GF Value™ of $23.23.
Key valuation signals for HGYMF:
EV-to-EBITDA: 19.62 (155% above median its 10-year median of 7.68)
GF Value™: $23.23 vs. price of $34.99 (50.6% above fair value)
Industry Position: 31.2% above the Medical Devices & Instruments median
No single metric tells the full story. See the HGYMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hogy Medical Co Ltd develops and sells products that can be used to streamline operations and improve safety at healthcare facilities. Its products are used in hospitals' operating rooms, wards, material rooms, and administrative settings. Hogy Medical receives the majority of its revenue from sales of surgical-use products. Its key products include kit products, nonwoven products, and sterilization products. The kit products contain sterilized surgical supplies for use in a specific operation. The nonwoven products include gowns, caps, equipment covers, and other accessories. Hogy's primary sterilization product is the Mekkin bag, a sterilization pouch. The vast majority of Hogy's revenue is generated in Japan.
57GF Score
Get the complete analysis for HGYMF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HGYMF has been successfully added to your 
